PortfoliosLab logoPortfoliosLab logo
HYMC vs. RLMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HYMC vs. RLMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hycroft Mining Holding Corporation (HYMC) and Relmada Therapeutics, Inc. (RLMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HYMC achieves a 42.28% return, which is significantly higher than RLMD's 32.92% return.


HYMC

1D
2.98%
1M
-12.68%
YTD
42.28%
6M
191.80%
1Y
869.05%
3Y*
115.74%
5Y*
-1.57%
10Y*

RLMD

1D
-6.28%
1M
-15.97%
YTD
32.92%
6M
58.91%
1Y
806.14%
3Y*
31.40%
5Y*
-26.71%
10Y*
-5.28%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HYMC vs. RLMD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
HYMC
Hycroft Mining Holding Corporation
42.28%975.57%-9.80%-53.96%-13.30%-92.18%-24.03%4.59%3.02%
RLMD
Relmada Therapeutics, Inc.
32.92%828.85%-87.44%18.62%-84.51%-29.75%-17.77%747.83%69.12%

Correlation

The correlation between HYMC and RLMD is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 13, 2018

0.10

The correlation between HYMC and RLMD shifts across timeframes, from 0.10 (all time) to 0.21 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

HYMC:

$3.04B

RLMD:

$555.95M

EPS

HYMC:

-$1.64

RLMD:

-$1.06

PB Ratio

HYMC:

13.56

RLMD:

2.54

Total Revenue (TTM)

HYMC:

$0.00

RLMD:

$0.00

Gross Profit (TTM)

HYMC:

-$4.65M

RLMD:

$0.00

EBITDA (TTM)

HYMC:

-$69.17M

RLMD:

-$60.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HYMC vs. RLMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HYMC
HYMC Risk / Return Rank: 9898
Overall Rank
HYMC Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
HYMC Sortino Ratio Rank: 9696
Sortino Ratio Rank
HYMC Omega Ratio Rank: 9595
Omega Ratio Rank
HYMC Calmar Ratio Rank: 9999
Calmar Ratio Rank
HYMC Martin Ratio Rank: 9999
Martin Ratio Rank

RLMD
RLMD Risk / Return Rank: 9898
Overall Rank
RLMD Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
RLMD Sortino Ratio Rank: 9898
Sortino Ratio Rank
RLMD Omega Ratio Rank: 9696
Omega Ratio Rank
RLMD Calmar Ratio Rank: 9999
Calmar Ratio Rank
RLMD Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HYMC vs. RLMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hycroft Mining Holding Corporation (HYMC) and Relmada Therapeutics, Inc. (RLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


HYMCRLMDDifference

Sharpe ratio

Return per unit of total volatility

7.40

6.62

+0.78

Sortino ratio

Return per unit of downside risk

4.53

5.60

-1.07

Omega ratio

Gain probability vs. loss probability

1.57

1.61

-0.05

Calmar ratio

Return relative to maximum drawdown

21.77

21.13

+0.64

Martin ratio

Return relative to average drawdown

46.40

48.78

-2.37

HYMC vs. RLMD - Sharpe Ratio Comparison

The current HYMC Sharpe Ratio is 7.40, which is comparable to the RLMD Sharpe Ratio of 6.62. The chart below compares the historical Sharpe Ratios of HYMC and RLMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


HYMCRLMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

7.40

6.62

+0.78

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.01

-0.23

+0.22

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.05

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.10

-0.16

+0.06

Drawdowns

HYMC vs. RLMD - Drawdown Comparison

The maximum HYMC drawdown since its inception was -98.89%, roughly equal to the maximum RLMD drawdown of -99.66%. Use the drawdown chart below to compare losses from any high point for HYMC and RLMD.


Loading charts...

Drawdown Indicators


HYMCRLMDDifference

Max Drawdown

Largest peak-to-trough decline

-98.89%

-99.66%

+0.77%

Max Drawdown (1Y)

Largest decline over 1 year

-46.18%

-35.78%

-10.40%

Max Drawdown (3Y)

Largest decline over 3 years

-63.45%

-96.30%

+32.85%

Max Drawdown (5Y)

Largest decline over 5 years

-95.39%

-99.32%

+3.93%

Max Drawdown (10Y)

Largest decline over 10 years

-99.50%

Current Drawdown

Current decline from peak

-78.62%

-91.37%

+12.75%

Average Drawdown

Average peak-to-trough decline

-63.32%

-79.70%

+16.38%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.66%

15.50%

+6.16%

Volatility

HYMC vs. RLMD - Volatility Comparison

Hycroft Mining Holding Corporation (HYMC) has a higher volatility of 26.26% compared to Relmada Therapeutics, Inc. (RLMD) at 20.29%. This indicates that HYMC's price experiences larger fluctuations and is considered to be riskier than RLMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HYMCRLMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.26%

20.29%

+5.97%

Volatility (6M)

Calculated over the trailing 6-month period

93.43%

69.52%

+23.91%

Volatility (1Y)

Calculated over the trailing 1-year period

119.34%

123.22%

-3.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

152.46%

116.20%

+36.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

123.04%

114.30%

+8.74%

Dividends

HYMC vs. RLMD - Dividend Comparison

Neither HYMC nor RLMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

HYMC vs. RLMD - Financials Comparison

This section allows you to compare key financial metrics between Hycroft Mining Holding Corporation and Relmada Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M2022202320242025202600
(HYMC) Total Revenue
(RLMD) Total Revenue
Values in USD except per share items

Frequently Asked Questions


HYMC and RLMD have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HYMC has higher volatility (26.26%) compared to RLMD (20.29%). In terms of maximum drawdown, HYMC dropped -98.89% vs RLMD's -99.66%.

HYMC currently has the higher Sharpe Ratio (7.40 vs 6.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HYMC and RLMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer